LAI
TMO icon

Legal Advantage Investments’s Thermo Fisher Scientific TMO Stock Holding History

Legal Advantage Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.9M Buy
9,771
+1,507
+18% +$723K 1.72% 14
2026
Q1 		$4.06M Hold
8,264
– – 2.1% 17
2025
Q4 		$4.79M Sell
8,264
-90
-1% -$50.9K 2.22% 14
2025
Q3 		$4.05M Buy
8,354
+25
+0.3% +$11.6K 1.82% 24
2025
Q2 		$3.38M Buy
8,329
+100
+1% +$41.8K 1.58% 27
2025
Q1 		$4.09M Buy
8,229
+200
+2% +$108K 2.21% 14
2024
Q4 		$4.18M Sell
8,029
-125
-2% -$68.7K 2.21% 13
2024
Q3 		$5.04M Sell
8,154
-45
-0.5% -$26.6K 2.77% 9
2024
Q2 		$4.53M Hold
8,199
– – 2.61% 12
2024
Q1 		$4.77M Hold
8,199
– – 2.67% 10
2023
Q4 		$4.35M Buy
8,199
+42
+0.5% +$20.3K 2.62% 11
2023
Q3 		$4.13M Sell
8,157
-88
-1% -$46.9K 2.95% 9
2023
Q2 		$4.3M Buy
8,245
+425
+5% +$229K 2.87% 8
2023
Q1 		$4.51M Buy
7,820
+35
+0.4% +$19.7K 3.31% 6
2022
Q4 		$4.29M Hold
7,785
– – 3.52% 4
2022
Q3 		$3.95M Buy
7,785
+85
+1% +$47.6K 3.7% 4
2022
Q2 		$4.18M Buy
7,700
+500
+7% +$275K 4.08% 4
2022
Q1 		$4.25M Buy
7,200
+125
+2% +$71.8K 3.2% 6
2021
Q4 		$4.72M Sell
7,075
-120
-2% -$74.9K 3.2% 8
2021
Q3 		$4.11M Buy
7,195
+100
+1% +$54.9K 2.76% 11
2021
Q2 		$3.58M Buy
7,095
+2
+0% +$944 2.45% 14
2021
Q1 		$3.24M Buy
7,093
+10
+0.1% +$4.77K 2.42% 13
2020
Q4 		$3.3M Buy
+7,083
New +$3.32M 2.57% 13

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Legal Advantage Investments's TMO Position: Q2 2026 in Review

Legal Advantage Investments increased its Thermo Fisher Scientific (TMO) stake by 18% in Q2 2026, buying an estimated $723K and bringing the position to 9,771 shares worth $4.9M. The position accounts for 1.72% of the portfolio, ranked #14.

Legal Advantage Investments first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $5.04M in Q3 2024. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Legal Advantage Investments held 9,771 shares of Thermo Fisher Scientific worth $4.9M as of Q2 2026.
  • Legal Advantage Investments bought 1,507 Thermo Fisher Scientific shares in Q2 2026, an estimated $723K.
  • Thermo Fisher Scientific made up 1.72% of Legal Advantage Investments's portfolio in Q2 2026, its #14 holding.
  • Legal Advantage Investments first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • Legal Advantage Investments's Thermo Fisher Scientific position peaked at $5.04M in Q3 2024.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Legal Advantage Investments's 13F filing for Q2 2026, filed 15 Jul 2026.